drug-development

Documents about drug-development

• Graph representation learning: algorithm development and its application to early drug discovery#328220UBIRA ETheses
• Artificial Intelligence in Pharmaceutical Care: Transforming Drug Discovery, Development, and Patient-care Delivery.#421025NCBI PubMed Central
• Role of health digital twins in oncology drug development - a primer.#671260NCBI PubMed Central
• Editorial: Structural and functional venomics as a powerful approach for drug discovery and development#268715HAL (France)
• The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial#967972ClinicalTrials.gov
• Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development#686365OpenAlex
• Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users#967980ClinicalTrials.gov
• Advancements in development of novel class of HIV protease inhibitors#4720Europe PMC
• Development of numerical model to investigate a distribution of injected drug solution in the intradermal region#69003J-STAGE (Japan)
• Establishment of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers#184940ClinicalTrials.gov
• Computational Investigation of Allostery in Dihydroorotate Dehydrogenase (DHODH)#195221İzmir Yüksek Teknoloji Enstitüsü
• Drug repurposing: re-inventing therapies for cancer without re-entering the development pipeline—a review#376093PubMed Central
• Recommendations for the use of clinical outcome assessments in rare disease drug development.#399786NCBI PubMed Central
• Operationalizing Precision Medicine in Drug Development: Predictive Biomarkers, Companion Diagnostics, and Regulatory Pathways.#439145NCBI PubMed Central
• Development of a novel drug delivery system based on polymeric, thermoresponsive, hydrogel nanoparticles#463924DataCite
• Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists#907751ClinicalTrials.gov
• Introduction: Syncopated Sustainable Development (Sustainable Development, Agriculture, and the Challenge of Genetically Modified Organisms Symposium)#494047Digital Repository @ Maurer Law
• Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review#288237HAL (France)
• Development of a liquid overlay-based three-dimensional cell culture panel for drug screening applications#291690HAL (France)
• From data to discovery: The rise of information-theoretic predictive models in drug development.#122800NCBI PubMed Central
• Accelerated drug development using a digital formulator and a self-driving tableting data factory.#239823NCBI PubMed Central
• DIF: Concepts, Measurement, and Impact in Patient-Focused Drug Development and Regulatory Decision-Making.#269505NCBI PubMed Central
• Positive-Strand RNA Viral RdRps: From Structure Conservation and Activity Assay to Drug Development.#317870NCBI PubMed Central
• Extracting and Classifying Drug Discontinuations From Estonian Electronic Health Records: Development and Validation Study.#338722NCBI PubMed Central
• ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL SCIENCES: REDEFINING DISCOVERY, DEVELOPMENT, AND PATIENT SAFETY#628844DOAJ
• Gaps in AI-Driven Pharmacokinetic Property Prediction for Early Drug Development: A Scoping Review.#659631NCBI PubMed Central
• Powering Neurology Drug Development Trials to Reduce False Negative Results#784490Europe PMC
• Development Platform Construction and Application Promotion of Drug-Eluting Stents for Intracranial Aneurysm Interventional Therapy#889337ClinicalTrials.gov
• PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)#899001ClinicalTrials.gov
• 21 U.S.C. § 1705 — Development, submission, implementation, and assessment of National Drug Control Strategy#576905US Code (LII)
• Landscape of diabetic kidney disease drug clinical trials in China (2013-2023): global implications for innovation and policy#4616Europe PMC
• A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately#848525ClinicalTrials.gov
• The Computational Revolution in Natural Product Research: A Data-Driven Roadmap for Next-Generation Drug Development.#140676NCBI PubMed Central
• Public-Private Partnerships: Compound and Data Sharing in Drug Discovery and Development#163613WIPO
• Development and Implementation of an AI System for Generating Clinical Urine Drug Test Sign-Outs.#312469NCBI PubMed Central
• Mapping safety in space: the emerging role of spatial transcriptomics in safe drug development.#368091NCBI PubMed Central
• Pediatric Extrapolation in Neuropsychiatric Drug Development: Leveraging Pharmacokinetic and Pharmacodynamic Strategies to Facilitate FDA Approvals.#420993NCBI PubMed Central
• Safety, Tolerability and Pharmacokinetics of CDD-2101 in Health Volunteers#840658ClinicalTrials.gov
• Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis#841307ClinicalTrials.gov
• Effect of Exercise in Parkinsonism#848337ClinicalTrials.gov
• BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers#231315Europe PMC
• BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers#246387Europe PMC
• A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users#901669ClinicalTrials.gov
• Draft report on the annual session : Executive Board of the United Nations Development Programme and of the United Nations Population Fund, 6-17 June 1994, Geneva.#459168UN Digital Library
• AI-derived therapeutic development of a serotonin receptor-targeting drug for the treatment of opioid use disorder.#14845NCBI PubMed Central
• "Role of Artificial Intelligence in Drug Discovery and Development: A New Era in Pharmaceutical Sciences"#30182DataCite
• "Role of Artificial Intelligence in Drug Discovery and Development: A New Era in Pharmaceutical Sciences"#30183DataCite
• Current positioning and future development of belantamab mafodotin and other antibody-drug conjugates to treat multiple myeloma#320318IRIS
• From Models to Meaning: The Integrator Pharmacologist's Role in Advancing Health Equity Across the Drug Development Continuum.#388707NCBI PubMed Central
• A biomimetic tubuloid-on-a-chip for human renal fibrosis research and anti-fibrotic drug development.#404394NCBI PubMed Central